References
- 1. Manzano-Robleda MC, Barranco-Fragoso B, Uribe M et al, Portal vein thrombosis: What is new?, Annals of Hepatology, January-February, 2015;14(1):20-27. https://pubmed.ncbi.nlm.nih.gov/25536638/, Accessed: on 06.05.2020.
- 2. Gîrleanu I, Trifan A, Stanciu C, et al. Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture, World J Gastroenterol, October 2018;24(39):4419-4427, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196341/, Accessed on 06.05.2020.
- 3. Hoekstra J, Janssen HL. Vascular liver disorders (II): portal vein thrombosis, Neth J Med. 2009;67(2):46-53, https://pubmed.ncbi.nlm.nih.gov/19299846/, Accessed on 06.05.2020.
- 4. Vecerzan L, Boicean A, Cipăian CR, et al. The correlation between conventional coagulation tests and the study of thrombin generation in patients with liver cirrhosis, Acta Medica Transilvanica. 2019:24(2):31-33.
- 5. Chen H, Trilok G, Wang F, et al. A single hospital study on portal vein thrombosis in cirrhotic patients - clinical characteristics & risk factors, Indian J Med Res. 2014 Feb; 139(2):260-266.
- 6. Ushitora Y, Tashiro H, Takahashi S, et al. Splenectomy in chronic hepatic disorders: portal vein thrombosis and improvement of liver function. Dig Surg. 2011;28:9-14. [PubMed: 21293126].
- 7. Yue-Meng W, Yu-Hua Li, Hua-Mei Wu, et al. Portal Vein Thrombosis in Patients With Cirrhosis Undergoing Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors, Warfarin Efficacy, and Clinical Outcomes, Clinical and Applied Thrombosis/Hemostasis. 2018;24(3):462-470.
- 8. Lin RS, Lee FY, Lee SD, Tsai YT, Lin HC, Lu RH, et al. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. Journal of hepatology. 1995;22(2):165-72.
- 9. Smeeth L, Cook C, Thomas S, Hall AJ, Hubbard R, Vallance P. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet. 2006; 367:1075-9.
- 10. Levi M, Keller TT, van Gorp E, et al. Infection and inflammation and the coagulation system. Cardiovasc Res. 2003;60:26-39.
- 11. Basili S, Carnevale R, Nocella C, et al. Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis, Hepatology Communications. 2019;3(4).
- 12. Jong MK, Choon HDK, Jae-Won J, et al. C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion, World Journal of Surgical Oncology. 2013;11:92.
- 13. Hunt AH WB. Thrombosis of the portal vein in cirrhosis hepatis. Lancet. 1954;263(6806):281-4.
- 14. Amitrano L, Guardascione MA, Ames PR. Coagulation abnormalities in cirrhotic patients with portal vein thrombosis. Clinical laboratory. 2007;53(9-12):583-9.
- 15. Zocco MA, Di Stasio E, De Cristofaro R, Novi M, Ainora ME, Ponziani F, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. Journal of Hepatology. 2009;51(4):682-9.